Research Report Screener Results

Chart, Financials, Historical Prices, Industry, Insider, Messages, Profile, Reports, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 24-Nov-2009
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 36)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
24-Nov-09 New Constructs, LLC N/A ELGX: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
22-Nov-09 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: ENDOLOGIX INC 5 $25 View Abstract
20-Nov-09 Zacks Investment Research Inc. N/A ENDOLOGIX INC (ELGX) Zacks Company Snapshot 1 $10 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Industry Value Graph: ELGX , HCCI , ILMN , OCLS , RMTI -- MEDICAL SUPPLIES & EQUIPMENT 3 $4 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Value Graph: ENDOLOGIX -- ELGX 1 $4 View Abstract
20-Nov-09 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ENDOLOGIX INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 3 $20 View Abstract
16-Nov-09 Argus Research Corporation David Coleman Vickers Weekly Insider, 11/16/09 52 $50 View Abstract
16-Nov-09 PriceTarget Research, Inc. N/A Endologix has a current Overall Rating of C (Neutral). 7 $25 View Abstract
15-Nov-09 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: ENDOLOGIX INC 5 $25 View Abstract
11-Nov-09 Argus Research Corporation David Coleman Vickers Weekly Insider, 11/10/09 40 $50 View Abstract
Next 20

Brokerage Reports (Showing 1 to 3 of 3)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
28-Oct-09 Capstone Investments N/A ELGX: Q3 Revenues Increase 47% Y/Y to $13.8 million-Slightly Ahead of Expectations-BUY 6 $25 View Abstract
27-Oct-09 Thomson StreetEvents N/A ELGX - Event Transcript of Endologix Inc. conference call, Oct. 27, 2009 / 5:00pm ET 15 $75 View Abstract
12-Oct-09 Capstone Investments N/A ELGX: Superior Technology Leading To Market Share Gains-Initiating Coverage with BUY 22 $75 View Abstract

Independent Reports (Showing 1 to 10 of 33)

Release
Date Contributor Author Title Pages Price More Info
24-Nov-09 New Constructs, LLC N/A ELGX: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
22-Nov-09 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: ENDOLOGIX INC 5 $25 View Abstract
20-Nov-09 Zacks Investment Research Inc. N/A ENDOLOGIX INC (ELGX) Zacks Company Snapshot 1 $10 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Industry Value Graph: ELGX , HCCI , ILMN , OCLS , RMTI -- MEDICAL SUPPLIES & EQUIPMENT 3 $4 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Value Graph: ENDOLOGIX -- ELGX 1 $4 View Abstract
20-Nov-09 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ENDOLOGIX INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 3 $20 View Abstract
16-Nov-09 Argus Research Corporation David Coleman Vickers Weekly Insider, 11/16/09 52 $50 View Abstract
16-Nov-09 PriceTarget Research, Inc. N/A Endologix has a current Overall Rating of C (Neutral). 7 $25 View Abstract
15-Nov-09 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: ENDOLOGIX INC 5 $25 View Abstract
11-Nov-09 Argus Research Corporation David Coleman Vickers Weekly Insider, 11/10/09 40 $50 View Abstract
Next 20

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.